Richard Turkington

Academic Clinical, School of Medicine, Dentistry and Biomedical Sciences
Academic Clinical, Centre for Cancer Research and Cell Biology

Phone+44 (0)28 9097 2756
EmailR.Turkington@qub.ac.uk

Room 02.017 - H.S.B
United Kingdom

Accepting PhD Students

PhD projects

Dr Turkington is open to PhD applications in the fields of: - Laboratory based investigations of novel drugs and biomarkers - Discovery of resistance mechanisms to therapy - Innovative biomarker development using clinical samples

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Richard Turkington is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

58 Similar Profiles

Adenocarcinoma Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Drug Therapy Medicine & Life Sciences

Cohort Studies Medicine & Life Sciences

Survival Medicine & Life Sciences

Barrett Esophagus Medicine & Life Sciences

oxaliplatin Medicine & Life Sciences

Colorectal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2016

1 Active

R6547CNR: Training in Cancer Mechanisms and Therapeutics

Turkington, R. & Blayney, J.

29/09/2016 → …

Project: Research

Research Output 2007 2020

25 Article
7 Abstract
6 Meeting abstract
2 Patent
3 More

3 Downloads (Pure)

Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study

McCain, R. S., McManus, D. T., McQuaid, S., James, J. A., Salto-Tellez, M., Reid, N. B., Craig, S., Chisambo, C., Bingham, V., McCarron, E., Parkes, E., Turkington, R. C. & Coleman, H. G., 01 Jan 2020, In : Cancer Causes and Control. 31, 1, p. 1-11

Research output: Contribution to journal › Article

Open Access

File

Molecular Epidemiology

Molecular Pathology

Adenocarcinoma

Cohort Studies

Smoking

Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma

Thomas, A., Virdee, P. S., Eatock, M., Lord, S. R., Falk, S., Anthoney, D. A., Turkington, R. C., Goff, M., Elhussein, L., Collins, L., Love, S., Moschandreas, J. & Middleton, M. R., Jan 2020, In : European Journal of Cancer. 124, p. 131-141 11 p.

Research output: Contribution to journal › Article

Open Access

File

oxaliplatin

Stomach Neoplasms

Adenocarcinoma

Safety

Drug Therapy

79 Downloads (Pure)

Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1

the OCCAMS consortium, 22 Jan 2019, In : Scientific Reports. 9, 318.

Research output: Contribution to journal › Comment/debate

Open Access

File

Adenocarcinoma

Cell Line

1 Citation (Scopus)

External validation of a model to determine risk of progression of Barrett’s oesophagus to neoplasia

Kunzmann, A. T., Thrift, A. P., Johnston, B. T., McManus, D. T., Gavin, A. T., Turkington, R. C. & Coleman, H. G., 01 May 2019, In : Alimentary Pharmacology and Therapeutics. 49, 10, p. 1274-1281

Research output: Contribution to journal › Article

Barrett Esophagus

Neoplasms

ROC Curve

Adenocarcinoma

Smoking

2 Citations (Scopus)

115 Downloads (Pure)

Immune Activation by DNA Damage Predicts Response to Chemotherapy and Survival in Oesophageal Adenocarcinoma

Turkington, R., Knight, L., Blayney, J., Secrier, M., Douglas, R., Parkes, E., Sutton, E., Stevenson, L., McManus, D., Halliday, S., McCavigan, A., Logan, G., Walker, S., Steele, C., Perner, J., Bornscein, J., MacRae, S., Miremadi, A., mccarron, E., McQuaid, S. & 10 others, Arthur, K., James, J., Eatock, M., O'Neill, R., Noble, F., Underwood, T., Harkin, D., Salto-Tellez, M., Fitzgerald, R. C. & Kennedy, R., 09 Mar 2019, In : Gut. 10 p.

Research output: Contribution to journal › Article

Open Access

File

DNA Damage

Adenocarcinoma

Drug Therapy

Survival

Adjuvant Chemotherapy